رجوع
نطاق اليوم
KWD 4.34
KWD 4.61
نطاق 52 أسبوعًا
KWD 0.40
KWD 8.21
حجم التداول
4,402,975
متوسط 50 يوم / 200 يوم
KWD 5.24
/
KWD 3.55
الإغلاق السابق
KWD 4.45
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -43.7 | 0.4 |
| P/B | 7.7 | 2.9 |
| ROE % | -35.3 | 3.7 |
| Net Margin % | -22.8 | 3.8 |
| Rev Growth 5Y % | 19.5 | 10.0 |
| D/E | 0.0 | 0.2 |
النقاط الرئيسية
Revenue grew 19.54% annually over 5 years — strong growth
Earnings declined -154.50% over the past year
Debt/Equity of 0.04 — conservative balance sheet
Negative free cash flow of -75.81M
PEG of 0.24 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 64.36%
النمو
Revenue Growth (5Y)
19.54%
Revenue (1Y)-44.82%
Earnings (1Y)-154.50%
FCF Growth (3Y)N/A
الجودة
Return on Equity
-35.25%
ROIC-14.21%
Net Margin-22.79%
Op. Margin-25.67%
الأمان
Debt / Equity
0.04
Current Ratio3.09
Interest Coverage0.00
التقييم
P/E Ratio
-43.70
P/B Ratio7.67
EV/EBITDAN/A
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -44.82% | Revenue Growth (3Y) | -13.23% |
| Earnings Growth (1Y) | -154.50% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 19.54% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 76.20M | Net Income (TTM) | -17.37M |
| ROE | -35.25% | ROA | -11.46% |
| Gross Margin | 100.00% | Operating Margin | -25.67% |
| Net Margin | -22.79% | Free Cash Flow (TTM) | -75.81M |
| ROIC | -14.21% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.04 | Current Ratio | 3.09 |
| Interest Coverage | 0.00 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | -43.70 | P/B Ratio | 7.67 |
| P/S Ratio | 9.96 | PEG Ratio | 0.24 |
| EV/EBITDA | N/A | Dividend Yield | 0.01% |
| Market Cap | 759.03M | Enterprise Value | 750.61M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 76.20M | 138.10M | 101.21M | 53.16M | 37.31M |
| Net Income | -17.37M | 31.87M | -569,000.0 | -99.32M | -115.87M |
| EPS (Diluted) | -0.15 | 0.38 | -0.01 | -1.48 | -1.26 |
| Gross Profit | 76.20M | 138.10M | 101.21M | 53.16M | 37.31M |
| Operating Income | -19.56M | 25.00M | -6.48M | -101.34M | -116.04M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 151.57M | 120.53M | 201.79M | 260.89M | 339.41M |
| Total Liabilities | 52.56M | 120.99M | 249.24M | 346.64M | 339.87M |
| Shareholders' Equity | 99.01M | -456,000.0 | -47.45M | -85.75M | -459,000.0 |
| Total Debt | 4.24M | 9.39M | 13.97M | 18.06M | 21.67M |
| Cash & Equivalents | 12.67M | 38.05M | 17.17M | 193.65M | 205.53M |
| Current Assets | 143.92M | 107.31M | 182.94M | 237.10M | 310.30M |
| Current Liabilities | 46.62M | 85.77M | 155.91M | 152.61M | 77.87M |